Because the promoter methylation of E2F1-dependent proapoptotic genes is a step in apoptotic defense mechanisms,12 the simultaneous inhibition of both SET9 and DNMT1 in the presence of DNA damage may be required to favor the tumor-suppressor function of E2F1. This evidence concerns the gene SETD7 and neoplasm.